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Low molecular weight heparin (LMWH) is routinely
used in association with aspirin in the treatment
of unstable angina.1 Since the publication of the
CURE study,2 clopidogrel is now also part of the
standard treatment regime for acute coronary syn-
dromes. It is well recognized that each of these thera-
pies increase bleeding risk. Here we present a
previously unreported complication of LMWH and
anti-platelet therapy ± that of spontaneous rupture of
a varicose vein with subsequent massive haematoma
formation in the posterior superficial compartment of
the calf.
Case History
A 71-year-old man with known ischaemic heart dis-
ease presented to his local hospital with unstable
angina. Thirteen years previously he had undergone
triple vessel coronary artery bypass grafting (CABG).
He had remained asymptomatic until two years prior
to this admission when he redeveloped symptoms of
exertional angina. Subsequent coronary angiography
confirmed occlusion of two vein grafts with critical
stenosis of the third. At the time of presentation he
was on the waiting list for a repeat CABG.Please address all correspondence to: T. M. Maher, Department of
Cardiology, St Bartholomew's Hospital, Dominion House, 60
Bartholomew's Close, London, EC1A 7BE, U.K.
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iorly and antero-lateral T wave inversion. Laboratory
investigations revealed a rise in creatine kinase to
430 mmol/l. Full blood count, clotting screen and
urea and electrolytes were normal with a creatinine
of 108 mmol/l. A diagnosis of non Q wave antero-
lateral myocardial infarct was made and LMWH was
administered for six days. The patient was already on
aspirin 75 mg daily. He was also commenced on
clopidogrel 75 mg daily.
Transfer to our hospital was arranged to facilitate an
urgent CABG. Ten days later, because of recurrent
resting angina, Enoxaparin was restarted at a dose of
1 mg/kg twice daily. Aspirin 75 mg daily and Clopi-
dogrel 75 mg daily were continued. Seven days after
being commenced on this treatment the patient com-
plained of pain and swelling in his right calf. There
was no history of preceding trauma. Examination
revealed large varicose veins over the right leg
which had developed following saphenous vein har-
vesting thirteen years earlier. The right calf was swol-
len, with a circumference 10 cms greater than that of
the unaffected left calf. The overlying skin was
bruised and deeply discoloured. A 15 cm 10 cm
blood filled blister developed over the calf and subse-
quently ruptured to leave an area of desquamated
skin (Fig. 1). The calf was tender to palpation. Sensa-
tion and distal pulses remained intact. An ultrasound
scan confirmed the presence of a large haematoma
12.1 cm 7.7 cm 4.9 cm. There was no evidence of
deep vein thrombosis on Doppler ultrasound examin-
ation. A drop of 2.7 g/dl in haemoglobin level wascense.
Fig. 1. Right calf, posterior superficial compartment haematoma
with overlying area of desquamated skin. Distended varicose
veins and saphenous vein harvest scar are also clearly visible.
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250 109/L. A clinical diagnosis of spontaneous rup-
ture of a varicose vein into the posterior superficial
compartment of the calf secondary to LMWH and
anti-platelet therapy was made.
All anti-platelet and anticoagulant medication was
withdrawn and the haematoma was treated conserva-
tively with elevation. Compression dressings were
not tolerated because of pain. Due to the need for
anticoagulation during CABG surgery and the risk of
further bleeding, surgery was postponed. The haem-
atoma gradually resolved over a period of six weeks
with conservative management.
Discussion
Enoxaparin, in common with other LMWHs, is a gly-
cosaminoglcan with a molecular weight of approxi-
mately 5000 kDa. It acts by binding antithrombin,
resulting in a conformational change which greatly
accelerates the interaction of antithrombin with
thrombin and activated factor Xa. LMWHs have a
more predictable dose response than unfractionated
heparin and have the added benefit of not requiring
regular blood monitoring.3 Clopidogrel is a thienopyr-
idine derivative that inhibits platelet aggrega-
tion induced by adenosine diphosphate.2 Aspirin
inhibits platelet function by its action on thromboxane
synthesis.
LMWH, aspirin and clopidogrel have all been pro-
ven to significantly reduce morbidity and mortality in
patients with unstable angina.2,4,5 This benefit comes
at the expense of increased bleeding complications. In
trials of LMWH in patients with acute coronary syn-
dromes the incidence of major bleeding events isbetween 0.8±6.5% and the incidence of minor bleeding
complications is between 3.1±11.9%.5±7 In the CURE
trial, the treatment arm receiving aspirin and clopido-
grel had a 3.7% incidence of major bleeding events
compared to 2.7% for patients receiving aspirin and
placebo.2
The majority of excess bleeds reported in these trials
were eccymoses or haematomas at sites of vascular or
dermal puncture. Major bleeds tended to occur most
commonly in the gastrointestinal tract. However,
intracranial, intraocular and retroperitoneal bleeds
were reported in trials involving both LMWH and
anti-platelet therapy.2,4±7 Other bleeding complica-
tions of LMWH reported in the literature include
spontaneous abdominal wall haematomas,8 anterior
tibial compartment syndrome,9 spontaneous splenic
rupture10 and intrahepatic haemorrhage.11
The aetiology of spontaneous haemorrhage in
patients treated with LMWH remains unclear. It is
known that unfractionated heparins increase micro-
vascular permeability, that they inhibit platelet func-
tion and that they interfere with the generation of
von Willebrand factor.3 Animal and laboratory
studies suggest that while LMWHs have these
effects they are less significant than those of unfractio-
nated heparin.12 There is also no clear correlation
between duration of treatment and bleeding risk.
In the FRISC II study13 Dalteparin, a LMWH, was
administered for three months continuously with
only a 3.3% incidence of major bleeding events
during that time. Impaired renal function reduces
the excretion of LMWH and has been demonstrated
to be associated with an increase in major bleeding
complications.14
Varicose veins are a common problem with an esti-
mated incidence of about 2% in the European popula-
tion.15 Spontaneous haemorrhage is a recognized,
albeit rare, complication of varicose veins.16 Such
haemorrhage is usually superficial and can be mana-
ged by compression and elevation of the bleeding
vein. A search of the literature provided a single ref-
erence to spontaneous bleeding of varicose veins.17
This was a case series of 21 patients across the UK
who died in 1971 and whose cause of death was
recorded as being due to haemorrhage from varicose
veins. In 17 of these 21 cases the patients had varicose
leg ulcers which had eroded through dilated veins
thus precipitating the haemorrhage. None of these
patients was on anticoagulant medication. There are
no reports in the literature of varicose veins bleeding
into the fascial compartments of the calf.
This case further highlights that the use of LMWH
and anti-platelet medication is associated with a clin-
ically significant risk of bleeding complications.EJVES Extra, 2002
96 T. M. Maher et al.Haemorrhage can occur at almost any site and in the
absence of trauma. Furthermore, spontaneous bleed-
ing is an important and potentially life threatening
complication of varicose veins. Early recognition,
compression and elevation are all important in the
management of bleeding veins. In more severe cases
injection sclerotherapy or stripping of varicose veins
may be necessary.
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